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Abstract 
The COVID-19 pandemic continues to ravage the world, with the United States being highly affected. 
A vaccine provides the best hope for a permanent solution to controlling the pandemic. Several 
coronavirus disease (COVID-19) vaccines are currently in human trials. However, to be effective, a 
vaccine must be accepted and used by a large majority of the population. This study aimed to investigate 
the acceptability of COVID-19 vaccines and its predictors in addition to the attitudes towards these 
vaccines among public. This study did an online survey during the period June-September 2020, were 
collected from 26,852 individuals aged 19 years or older across six continents as part of 60 nationally 
representative surveys to determine potential acceptance rates and factors influencing acceptance of a 
COVID-19 vaccine. Results revealed that two-thirds of respondents were at least moderately worried 
about a widespread COVID-19 outbreak. Differences in acceptance rates ranged from almost 93% (in 
Tonga) to less than 43% (in Egypt). Respondents reporting higher levels of trust in information from 
government sources were more likely to accept a vaccine and take their employer’s advice to do so. 
Systematic interventions are required by public health authorities to reduce the levels of vaccines’ 
hesitancy and improve their acceptance. These results and specifically the low rate of acceptability is 
alarming to public health authorities and should stir further studies on the root causes and the need of 
awareness campaigns. These interventions should take the form of reviving the trust in national health 
authorities and structured awareness campaigns that offer transparent information about the safety and 
efficacy of the vaccines and the technology that was utilized in their production.  
Keywords: Novel Coronavirus, COVID-19, pandemic, outbreak, vaccine, knowledge, attitude, 
acceptance
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Vaccines are a key strategy to stop the 
escalation of the COVID19 pandemic. As 
of April 8, 2020, there were more than 100 
COVID-19 vaccine candidates being 
developed (Pogue et al 2020). This 
vaccine development is proceeding at a 
fast pace; prior to March 30, 2020, two 
vaccine candidates had entered Phase 1 
clinical trials (Lurie et al 2020) while on 
April 9, five vaccine candidates in total 
were in Phase 1 clinical trials (Thanh Le et 
al 2020). Understanding vaccine 
acceptance is important, given the large 
population and because it has relatively 
high vaccine hesitancy for existing 
vaccines and relatively low vaccination 
coverage (van Doremalen et al 2020; 
Harapan et al 2019). Characterizing how 
vaccine efficacy could impact acceptance 
is also important, given that actual or 
perceived vaccine efficacy could be 
relatively low. 
The high usage of news media is 
concerning given the potential for 
alarming, sensationalist portrayals of the 
pandemic (Klemm et al 2016). In addition, 
myths, rumors and misinformation can 
quickly spread online, particularly via 
social media (Vosoughi et al 2018). 
Reliance on social media might have 
contributed to uncertainty around COVID-
19, for example, about whether people 
have natural immunity and whether 
specific home remedies (garlic, vitamins, 
and rinsing noses with saline) help protect 
against coronavirus. It may also explain 
some uncertainty around whether the virus 
was human-made and deliberately 
released. Uncertainty and rapidly 
changing information may have 
contributed to increased worry about the 
virus (Han et al 2006). These findings 
speak to the importance of distributing 
accurate health information about 
COVID-19 through a variety of sources 
(news, social media, and government 
websites) to reach the general population 
and correct misinformation. 
The effect of media exposure may be 
related to the provision of important health 
information about the pandemic. Although 
media exposure early in the outbreak 
appears to have facilitated health-
protective behaviors, media fatigue—
where people become desensitized to 
ongoing messaging—may reduce this 
effect as the pandemic continues 
(Collinson et al 2015). Repeated media 
exposure may also lead to heightened 
stress and anxiety, which can have longer-
term health effects, as well as contributing 
to excessive or misplaced health-
protective behaviors such as presenting for 
diagnostic testing when actual risk of 
exposure is low (Garfin et al 2020). 
Emerging evidence from groups with 
widespread testing for the SARS-CoV-2 
virus indicates that between 2 and 8 out of 
every 10 infections may be asymptomatic 
(Mizumoto et al 2020; Nishiura et al 
2020). Despite being asymptomatic, those 
infected are still able to transmit the virus 
to others (Bai et al 2020; Zou et al 2020). 
In addition, people appear to be infectious 
and asymptomatic during the incubation 
period (Lauer et al 2020). People 
commonly rely on symptoms to indicate 
illness and assume that the absence of 
symptoms means they are well 
(Diefenbach & Leventhal 1996). Such 
assumptions in the COVID-19 pandemic 





could have serious consequences, in terms 
of both community transmission and 
reduced health-protective behaviors. 
Therefore, public health communication 
campaigns about COVID-19 need to 
address these misconceptions. 
There is an evident uncertainty clouding 
the COVID-19 vaccines. Firstly, the new 
mRNA-based vaccines as a novel 
technology could be received with some 
skepticism since no prior experience or 
successes with such approach have been 
reported in the past. Also, the speed of 
vaccine development and registration in 
less than a year may have mediated a role 
in lowering the acceptance level. Another 
global phenomenon that negatively 
contributed to such a low level is the 
numerous campaigns launched by anti-
vaccinationists fueled by the new 
technology and short span of vaccine 
development. Such campaigns on social 
media with fabricated, false, and 
sometimes misleading translations feed 
the conspiracy beliefs of some people. 
Some factors that are specific to the 
country and the region could also play a 
role in this. For example, there is a sector 
of the public who had their trust shaken in 
local authorities and/or disapprove the 
overall handling of the pandemic. Some 
people expresses their frustration as many 
decisions could be  unwelcomed, 
disproportional with the pandemic status, 
not justified or backed with science. 
COVID-19 pandemic as with other 
previous pandemics is associated with 
feelings of fears, anxiety, and worries 
(Blakey & Abramowitz 2017; Wheaton et 
al 2012). However, it is unique in terms 
that people are not worried only about 
getting infected or transmit the disease to 
others (Blakey & Abramowitz 2017), but 
they suffered societal and economic 
concerns due to the measures that were 
undertaken by the governments to confine 
the pandemic and stopping the human-
human transmission of the disease (Nicola 
et al 2020). These measures include 
enforcement of curfews and lockdowns 
(the largest throughout history), social 
distancing and self-isolation, schools and 
universities closures, borders’ shutdowns, 
travel restrictions, and quarantine 
(Mannan & Farhana 2020; Nicola et al 
2020). 
LITERATURE REVIEW 
Holingue et al showed in a population-
based study of US adults that the fears and 
anxiety of getting infected with and die 
from COVID-19 were associated with 
increased mental distress (Holingue et al 
2020). Moreover, the personal hygienic 
precautions that were undertaken by 
individuals to avoid infecting others had 
increased the probability of becoming 
mentally distressed (Holingue et al 2020). 
A systematic review and meta-analysis of 
the psychological and mental impact of 
COVID-19 showed that the prevalence of 
anxiety and depression was 33% and 28%, 
respectively (Luo et al 2020). During the 
COVID-19 pandemic, people used 
multiple information resources to gain 
knowledge and health information about 
the disease, including television, radio, 
newspapers, social media, friends, co-
workers, healthcare providers, scientists, 
governments, etc. (Ali et al 2020). Since 
such information sources can shape 
peoples’ acceptance or refusal of COVID-
19 vaccines[44], it is crucial to 





disseminate transparent and accurate 
information about vaccines' safety and 
efficacy to gain the trust of the population 
especially the hesitant and skeptical ones 
(Siegrist, & Zingg 2014). Hence, gaining 
an understanding of the resources that 
people trust the most to get information 
about COVID-19 vaccines is critical for 
the success of any future national 
vaccination campaign.  
In a further study, COVID-19 vaccine 
acceptance among college students in 
South Carolina was found to be affected 
by the information resources. Students 
largely trusted scientists (83%), followed 
by healthcare providers (74%), and then 
health agencies (70%) (Qiao et al 2020). In 
a study from France, vaccination practices 
and acceptance toward MMR and HBV 
vaccines were better when parents had 
reported getting the information from their 
healthcare providers compared with 
parents getting information from the 
internet or their relatives (Charron et al 
2020). Recent research from China 
indicates that engaging in hand hygiene 
and other health protective behaviors was 
associated with reduced psychological 
impact of the COVID-19 outbreak, 
including lower stress and anxiety (Wang 
et al 2020). These findings highlight the 
importance of encouraging the public to 
engage with such behaviors not only to 
reduce the risk of infection but also to 
reduce anxiety associated with COVID-
19. 
Over the past decade, it has 
comprehensively explored the landscape 
of vaccine confidence issues and 
experiences in managing confidence crises 
around the world (Larson et al 2018; 2014; 
2011; Jarrett et al 2015). The numerous 
surveys, focus groups, in-depth qualitative 
research, and large scale digital media 
analytics (Larson et al 2016; 2015; 2014), 
as well as convened expert roundtables 
and workshops to understand context 
specific attitudes to vaccines among the 
general public (Larson et al 2018; 2016), 
health-care professionals and providers 
(Larson et al 2018), and pregnant women 
(Wilson et al 2015). It continues to 
research the roots, trends, and impacts of 
vaccine confidence issues at national and 
supranational levels to inform policy and 
trust-building activities and mitigate the 
need for crisis management in 
immunisation programmes. 
These studies have focused that a 
multiplicity of factors influencing vaccine 
decisions (SAGE 2014), key drivers of 
public confidence in vaccines were 
identified as trust in the importance, 
safety, and effectiveness of vaccines, 
along with compatibility of vaccination 
with religious beliefs (Larson et al 2015). 
These findings have resulted in the 
development of a Vaccine Confidence 
Index survey tool to measure individual 
perceptions on the safety, importance, 
effectiveness, and religious compatibility 
of vaccines. The research questionnaire 
has the primary focus of measuring 
confidence across multiple countries while 
being minimal, thus allowing ready 
integration into existing global surveys. 
The survey is one of a diverse set of 
metrics and indices used to measure 
confidence or hesitancy such as the Parent 
Attitudes About Childhood Vaccines 
Survey, which measures vaccine hesitancy 
among parents (Opel et 2013); the 
Vaccination Confidence Scale, which 





measures confidence in adolescent 
vaccination (Gilkey et al 2014); the 5-C 
scale  such as confidence, complacency, 
constraints, calculation, and collective 
responsibility, which identifies 
psychological barriers of vaccination 
behavior (Betsch et al 2018); and the 
SAGE Vaccine Hesitancy Scale, which 
has been deployed across multiple 
countries (Wagner et al 2019; Shapiro et al 
2018; Domek et al 2018; Masters et al 
2018; Ren et al 2018). 
In 2017, the vaccine manufacturer Sanofi 
announced that their newly introduced 
dengue vaccine Dengvaxia posed a risk to 
individuals who had not previously been 
exposed to the virus, prompting outrage 
and panic across the population where 
nearly 850 000 children had been given the 
new vaccine the previous year. As the 
research measured a baseline confidence 
value in 2015, that were able to measure 
the change in confidence following the 
vaccine scare and found a significant drop 
in confidence in vaccine importance, 
safety, effectiveness (Larson et al 2019). 
The survey study tool has detected a rise in 
confidence across the country—although 
confidence is not back to 2015 levels—
indicating a possible recovery and 
highlighting the value of the tool in 
assessing the effectiveness of national-
level policy. 
Japan ranked among the countries with the 
lowest vaccine confidence in the world: 
this might be linked to the human 
papillomavirus (HPV) vaccine safety 
scares that started in 2013, and following 
the decision by the Japanese Ministry of 
Health, Labour and Welfare in June, 2013, 
to suspend proactive recommendation of 
the HPV vaccine (Simms et al 2020). As a 
result of this vaccine safety scare, HPV 
vaccination coverage decreased from 
68•4–74•0% in the 1994–98 birth cohort to 
0•6% in the 2000 birth cohort.36 The news 
of Japan suspending their proactive 
recommendation of the HPV vaccine has 
travelled globally through online media 
and social media networks, being 
applauded by ant vaccination groups but 
not by the global scientific community 
(Larson et al 2014). 
Moreover, Indonesia witnessed a large 
drop in confidence between 2015 and 
2019, partly triggered by Muslim leaders 
questioning the safety of the measles, 
mumps, and rubella (MMR) vaccine, and 
ultimately issuing a fatwa—a religious 
ruling—claiming that the vaccine was 
haram and contained ingredients derived 
from pigs and thus not acceptable for 
Muslims. Local healers promoting natural 
alternatives to vaccines also contributed to 
the waning confidence in vaccines 
(Rochmyaningsih 2018; Yufika et al 
2020). In addition, In South Korea and 
Malaysia, online mobilization against 
vaccines has been identified as a key 
barrier to vaccination (Wong et al 2020; 
Chang & Lee 2019). In South Korea, an 
online community named ANAKI 
(Korean abbreviation of ‘raising children 
without medication’) has been strongly 
advocating against childhood 
immunization (Park et al 2018). The 
internet is a main source of vaccination 
information in Malaysia, where 
misinformation has been identified as 
influencing vaccine reluctance (Mohd 
Azizi et al 2017). In Georgia, unfounded 
vaccine safety concerns, amplified by the 
media, were found to profoundly affect a 





nationwide MMR vaccine campaign in 
2008 (Khetsuriani et al 2010). 
Furthermore, other studies in Asia have 
found that perceived risk or perceived 
susceptibility to an infection is associated 
with positive support for vaccination 
(Rajamoorthy et al 2019; Rajamoorthy et 
al 2018; Sundaram et al 2015). Another 
study also found that high perceived risk 
was associated with COVID-19 vaccine 
acceptance among general community 
members in Saudi Arabia (Padhi & 
Almohaithef 2020) and among HCWs in 
China (Fu et al 2020). Low perceived risk 
may not only be correlated with vaccine 
acceptance, but also adherence to social 
distancing measures and other public 
health countermeasures. These 
relationships may be complicated—for 
example, an individual highly compliant 
with social distancing measures may 
perceive their risk to be low but still want 
to obtain a vaccine. Lower vaccine 
acceptance among the retired population 
might be influenced by lower perceived 
risk. Although the elderly are more 
vulnerable to COVID-19, most of the 
retired population in Southeast Asian 
countries have low mobility and spend 
more time at home with less travel. These 
behaviors may lead them to having a lower 
perceived risk of being infected with 
SARS-CoV-2, and eventually may lead to 
lower acceptance of a vaccine. Moreover, 
their acceptance might also be influenced 
by knowledge about the disease. Much of 
the information about COVID-19 is spread 
through social media or online media, 
which is less frequently accessed by older 
adults. Therefore, older adults might have 
less exposure to information about 
COVID-19 that could contribute to 
framing their risk perception. In addition, 
less social media use might also be 
associated with less knowledge among the 
elderly and this could affect their 
perceived risk and vaccine acceptance. 
METHODOLOGY 
Due to limitations in doing face-to-face 
research during the current active COVID-
19 outbreak, this study did an online 
survey during the period June-September 
2020, were collected from 26,852 
individuals aged 19 years or older across 
six continents as part of 60 nationally 
representative surveys. This grouped 
countries and territories by WHO regional 
classification. Online, and telephone 
survey methodologies were used. In 
addition to probing individuals’ 
knowledge, attitude and acceptances on 
vaccine confidence across the globe, the 
study was also surveyed individuals on a 
range of factors including sources of trust, 
and information-seeking behaviours. The 
surveys were weighted by sex and age 
according to national distributions, with 
equal sex representation in most surveys. 
The questionnaire used in this study was 
developed based on literature review and 
discussion within the research team. The 
questionnaire was reviewed by experts in 
survey research for face validity. 
Participants were asked to indicate if they 
were infected with COVID-19 or knew 
anyone who was infected with 
confirmation of diagnosis using standard 
laboratory testing protocols. Another 
question item was dedicated to surveying 
participants who believe they may have 
contracted the virus but without a 
confirming test. Participants were asked to 





indicate their most trusted sources when 
seeking knowledge of COVID-19 
vaccines. Besides, participants were asked 
about their concerns during the COVID-19 
pandemic. Participants were asked 
whether they accept to receive COVID-19 
vaccines when they are approved and 
available. The attitudes towards COVID-
19 vaccines’ section consists of 10 
statements with a 5-point Likert scale 
(5=strongly agree, 4=agree, 3=neutral, 
2=disagree, 1=strongly disagree), with 
questions about hesitancy and concerns 
regarding COVID-19 vaccines. 
Categorical variables were presented as 
numbers and percentages, while 
continuous variables were presented as 
median.. The univariate analysis was 
performed using an independent Mann–
Whitney U test for continuous variables 
and Chi-square test for categorical 
variables as appropriate. For analysis, 
responses to the attitudes section were 
combined.  
The main outcome of the study was the 
public acceptance of COVID-19 vaccines. 
To determine the factors that affect the 
acceptance of the population to receive 
COVID-19 vaccines, both multinomial 
and binary logistic regressions were 
performed. At first, potential predictors for 
COVID19 vaccines were screened using 
univariable analysis, and variables with 
p<.05 were considered in both 
multinomial and binary logistic 
regression. When the multinomial logistic 
regression was conducted, the acceptance 
outcome was trichotomized as (non-
acceptance, neutral, and acceptance). For a 
simpler interpretation of the analysis, the 
participants who answered ‘neutral’ were 
then removed and a binary logistic 
regression was performed. In the binary 
logistic regression model, the participants 
were dichotomized as acceptable or not 
acceptable. In both models, the odds ratio 
(OR) values and their 95% confidence 
intervals (95% CI) were calculated. A p-
value of less than .05 was considered 
statistically significant. The analysis was 
carried out using the Statistical Package 
for Social Sciences (SPSS). 
To assess knowledge, participants were 
asked to respond to a series of statements 
about the COVID19 coronavirus and 
whether these statements were true or false 
or they were unsure of the answer (Farhana 
& Mannan 2020). Correctly answered 
items were summed to generate a general 
virus knowledge subscale score. 
Participants were asked to identify the 
most common symptoms of COVID-19 
infection, based on information provided 
to the public at the time: fever, cough, sore 
throat, and shortness of breath. More 
recent information includes fatigue or 
tiredness, which were not included in the 
survey. Three uncommon symptoms were 
included: diarrhea, vomiting, and nausea 
(Guan et al 2020). The number of correctly 
answered items was summed to generate a 
symptoms knowledge subscale score. 
Transmission knowledge items asked 
about the ways the virus can potentially be 
spread, including droplets spread through 
coughing or sneezing, touching or shaking 
hands with someone who is infected, and 
touching surfaces that have come into 
contact with the virus. Three other sources, 
which did not appear to be transmission 
mechanisms, were also included: water, 
mosquitoes, and airborne spread (Centers 
for Disease Control and Prevention, 2020; 
World Health Organization, 2020a,b). One 





item assessed knowledge of recommended 
face mask use, with advice to the public at 
that time being that only people who were 
sick should be wearing masks to stop them 
spreading the virus.  
RESULTS AND DISCUSSIONS 
Information was collected on participants’ 
age group, gender, ethnicity, highest level 
of education, and region of residence 
around six continents as shown in Table 
1.1. Participants were also asked to 
complete few questions. Firstly, they were 
a single-item measure assessing their self-
rated heath (Idler & Benyamini, 1997), 
with responses on Likert scale.  Secondly, 
respondents were an item assessing 
whether they had received a flu vaccine in 
the previous year (yes, no, don’t know). 
For the purposes of analysis, no and don’t 
know responses were combined to form a 
dichotomous measure. Finally, 
participants were asked whether they, or 
any family members or friends, had caught 
























Table 1.1 Demographic characteristics of the sample with number (percentage) of 
respondents 
 
Respondents were asked to a series of 
true–false questions to assess their more 
general knowledge of COVID-19. 
Knowledge questions were also asked 
relating to most common symptoms and 
routes of transmission. The percentage of 
true, false, and don’t know responses can 
be seen in Table 1.2. Total general virus 
knowledge subscale scores ranged from 1 











Table 1.2 Percentage of true, false, and unsure responses to general knowledge 
 
Respondents were more accurate in 
recognizing the symptoms that have been 
linked with COVID-19 and less certain of 
whether the other symptoms were 
indicative of illness. Symptoms 
knowledge subscale scores ranged from 1 
to 8. The subscale score was, indicating 
good recognition of the symptoms 
commonly mentioned in public health 
information provided to the public at this 
time. Respondents typically recognized 
transmission routes associated with 
droplet spread but were less certain of 
whether the virus can also spread via air, 
water, or insects. Transmission knowledge 











Table 1.3 Percentage of yes, no, and don’t know responses to symptoms and 
transmission 
 
The results of the survey provide 
information on public knowledge in the 
early period of the COVID-19 pandemic. 
Majority of respondents were at least 
moderately worried about the possibility 
of a widespread outbreak. These rates are 
commensurate with past pandemics such 
as SARS (Bults et al 2011; Wheaton et al 
2012). Recent research from China 
indicates that engaging in hand hygiene 
and other health protective behaviors was 
associated with reduced psychological 
impact of the COVID-19 outbreak, 
including lower stress and anxiety 
(Mannan et al 2020; Wang et al 2020). 
These findings highlight the importance of 
encouraging the public to engage with 
such behaviors not only to reduce the risk 
of infection but also to reduce anxiety 
associated with COVID-19. This study 
also provide important insights into what 
participants expected in terms of how 
serious the symptoms of coronavirus 
would be, should they contract COVID-
19. There is a clear discrepancy between 
respondents’ perceived severity of 
symptoms and current data on rates of 
asymptomatic infection.  The results also 
provide insights into where residents are 
seeking their information about COVID-
19 and their level of knowledge about the 
virus and is transmission. While it was 
promising to see sourced information from 
official and government websites, 
mainstream news media was the most 
popular, and social media use was also 
high. 
This paper provided important insights 
into what participants expected in terms of 
how serious the symptoms of coronavirus 
would be, should they contract COVID-
19. There is a clear discrepancy between 
respondents’ perceived severity of 





symptoms and current data on rates of 
asymptomatic infection. Very few 
participants believed that they would 
experience no symptoms. In contrast, 
emerging evidence from groups with 
widespread testing for the SARS-CoV-2 
virus indicates that between 2 and 8 out of 
every 10 infections may be asymptomatic 
(Mizumoto et al 2020; Nishiura et al 
2020). Despite being asymptomatic, those 
infected are still able to transmit the virus 
to others (Bai et al 2020; Zou et al 2020). 
In addition, people appear to be infectious 
and asymptomatic during the incubation 
period (Lauer et al., 2020). People 
commonly rely on symptoms to indicate 
illness and assume that the absence of 
symptoms means they are well 
(Diefenbach & Leventhal, 1996). Such 
assumptions in the COVID-19 pandemic 
could have serious consequences, in terms 
of both community transmission and 
reduced health-protective behaviors. 
Therefore, public health communication 
campaigns about COVID-19 need to 
address these misconceptions. 
Majority (81.5%) of the participants were 
strongly agreed that it is important to get a 
vaccine to protect people from COVID-19. 
Besides, less than 59% of the participants 
agreed that pharmaceutical companies will 
be able to develop safe and effective 
COVID-19 vaccines. Moreover, about half 
of the respondents (51.6%) reported that 
side effects will prevent them from taking 
a COVID-19 vaccine and that 52.1% will 
refuse to take COVID-19 vaccines once 
licensed. Importantly, around a quarter of 
all respondents were neutral regarding 
most attitudes as shown in Table 1.4  
 
Table 1.4. Attitudes toward COVID-19 vaccines in percentage 
 





Further, the trust in the manufacturer that 
provides effective and noncontaminated 
products is another important determinant 
of confidence. About two-thirds of 
respondents in the current study had 
confidence in pharmaceutical companies 
to develop safe and effective COVID19 
vaccines. However, the source of the 
vaccine affects the perceived safety, as 
only one-third of the participants in the 
current study perceived that COVID-19 
vaccines that were manufactured in 
Europe or America were safer than those 
made in other countries. This is rather 
lower than the reported percentage by 
Pogue and colleagues where ~55% and 
36% of participants stated that they were 
more comfortable with vaccines made in 
the USA and Europe, respectively (Pogue 
et al 2020). 
Respondents from African continent, 
Mauritius gave the highest proportion of 
positive responses (82.76%) and the 
lowest proportion of responses from Egypt 
(43.55%) when asked if they would take a 
‘when vaccine will available in your 
country’. Participants from Asian 
continent, China gave the highest 
proportion of positive responses (87.42 %) 
and the lowest proportion of responses 
from Afghanistan (47.22%) when asked if 
they would take a ‘when vaccine will 
available in your country’. Respondents 
from Australian continent, Tonga gave the 
highest proportion of positive responses 
(92.88%) and the lowest proportion of 
responses from Fiji (87.21%) when asked 
if they would take a ‘when vaccine will 
available in your country’. There was 
considerable variation by country, with 
Tonga from Australian continent again 
having the highest proportion of positive 
responses (92.88%) and the lowest 
proportion of responses in Egypt (43.55 
%) from African continent. The proportion 
of positive responses for all three 
continents can be found in Table 1.5  
Table 1.5 COVID-19 Vaccine Acceptance in the Scale of Strongly Agreed in Africa, 
Asia and Australia Continents 
 
Respondents from North American 
continent, Panama gave the highest 
proportion of positive responses (87.44%) 
and the lowest proportion of responses 
from Canada (62.55%) when asked if they 
would take a ‘when vaccine will available 
in your country’. Participants from South 
American continent, Brazil gave the 
highest proportion of positive responses 
(86.24%) and the lowest proportion of 





responses from Paraguay (67.66%) when 
asked if they would take a ‘when vaccine 
will available in your country’. 
Respondents from European continent, 
England gave the highest proportion of 
positive responses (69.33%) and the 
lowest proportion of responses from 
Russia (51.34%) when asked if they would 
take a ‘when vaccine will available in your 
country’. There was considerable variation 
by country, with Panama from North 
American continent again having the 
highest proportion of positive responses 
(87.44%) and the lowest proportion of 
responses in Russia (51.34%) from 
African continent. The proportion of 
positive responses for all three continents 
can be found in Table 1.6  
Table 1.6 COVID-19 Vaccine Acceptance in the Scale of Strongly Agreed in North 
America, South America and Europe Continents 
 
Our findings provide insights into the 
demographic behaviors in the early stages 
of a pandemic disease outbreak. The 
results of this study shed light on how 
many respondents plan to get a COVID-19 
vaccine if available. Concern about the 
outbreak, greater media exposure, and 
higher knowledge predicted vaccination 
intentions. These findings are in line with 
previous research showing that concern 
and knowledge were associated with 
increased Ebola vaccine intentions (Petrie 
et al 2016). In contrast to previous 
research, perceived likelihood and severity 
of infection were only marginally 
associated with intentions to get a vaccine 
(Weinstein et al 2007; Bish & Michie 
2010). Previous research has typically 
focused on personal risk. In the case of 
COVID-19, the personal risk to most 
individuals is low, and behavior may be 
driven primarily by perceived risk to 
others, which was not assessed in the 










Table 1.7 Predictors of likelihood of getting vaccinated against COVID-19 if a vaccine 
becomes available 
 
The current study is strengthened by a 
large sample size and a good 
representation of participants from 
different educational backgrounds from 
the world. Respondents were recruited 
through Social Network and as such are 
not representative of the general 
population. The pattern of results may be 
generalize to the broader population. To 
maximize convenience sampling, we used 
solely self-report measures, which may 
lead to biased effects. While the results of 
the regression analyses provide interesting 
starting points to identify the demographic 
and risk variables that predict health 
behaviors and vaccine intentions, they 
cannot establish causality and must be 
interpreted with caution. Given the large 
sample, the relationships between some of 
the significant predictors are likely to be 
small and may not be clinically 
meaningful. 
The current results provide information on 
the public responses to the COVID-19 
pandemic, including information sources 
and engagement, knowledge, and vaccine 
intentions. The findings show that there 
was a critical mismatch between expected 





severities of symptoms versus data on how 
COVID-19 is experienced, which needs to 
be addressed in government education 
campaigns. Without a vaccine currently 
available, encouraging widespread and 
sustained engagement with hygiene and 
distancing behaviors is critical to 
successfully manage the COVID-19 
pandemic, flatten the curve of infections, 
and protect vulnerable individuals and 
overburdened healthcare systems. The 
results of the current study provide 
important insights into psychological and 
behavioral responses early in the outbreak 
of this COVID-19. The findings point to 
types of information that may be 
particularly effective and groups that may 
benefit from clear and targeted messaging 
to promote engagement with health-
protective behaviors.  
Vaccine hesitancy could threaten the 
efficiency of COVID-19 vaccines once 
they become commercially available 
worldwide (French et al 2020). There are 
contrasting reports of gender effects in the 
literature, wherein some males were more 
likely to accept the vaccine (Malik et al 
2020), compared to others reporting higher 
acceptance among females (Lazarus et al 
2020; Al-Mohaithef & Padhi 2020). In our 
study, males were more likely to take the 
vaccine, in agreement with studies 
reported elsewhere (Malik et al 2020). 
Interestingly, males were more likely to 
participate in COVID-19 vaccine clinical 
trials compared to females in 2020 (Abu-
Farha et al 2020). The low acceptance 
level of COVID-19 vaccines among them 
can be attributed to multi factors, some of 
which are shared with the wide global 
community. The current study revealed 
that half of the participants had safety 
concerns about the vaccine once it being 
available as indicated by their concerns 
about related side effects. This is 
consistent with Pogue and colleagues 
finding where the majority of participants 
(~63%) in the USA stated that they were 
worried about the side effects of the 
COVID-19 vaccines (Pogue et al 2020). 
Most of the participants in the current 
study stated that receiving the vaccine is 
important to protect against COVID-19. 
However, almost half of them agreed that 
most people would refuse to take the 
vaccine. This discrepancy could be due to 
their concerns about the vaccine’s side 
effects. Our results supported such 
perceived viewpoints, where those who 
did not believe in a conspiracy behind 
COVID-19 were more likely to accept 
COVID-19 vaccines. An important factor 
to consider when exploring vaccine 
acceptability is vaccine convenience in 
terms of its availability and affordability 
(MacDonald 2015). 
CONCLUSION 
The determinants of vaccine uptake across 
the globe show strong consistency, with 
being male or having fewer years of 
education associated with decreased 
chances of uptake. Positive information-
seeking behaviours and trusting health-
care workers more than other sources such 
as one’s social circle for medical and 
health advice were associated with 
increased chances of uptake. Results from 
our survey can inform the need for further 
research, to explore why certain countries 
might experience sudden increases or 
decreases in confidence. We have 
highlighted countries with marked 
decreases in percentages reporting that 





they strongly agree that vaccines are safe 
and countries with significant increases in 
those strongly disagreeing that vaccines 
are safe. These countries are candidates for 
more nuanced follow-up surveys to 
understand the precise drivers of 
confidence and the link between 
confidence and uptake. 
There is a study limitation to note. As not 
all surveys used have consistent responses, 
we have made a key assumption that, 
presented with different options between 
the extreme categories of “strongly agree” 
and “strongly disagree” (which are 
consistent across all surveys), respondents 
with the strongest sentiment will fall into 
one of these extreme groups regardless of 
additional categories. While this approach 
probably allows meaningful comparison 
across surveys—although it needs testing 
for validation—it pools vaccination beliefs 
among those without the strongest beliefs, 
masking potentially key information. 
Finally, owing to low case counts of 
respondents who have not had their 
children vaccinated and the varying 
religious groups across countries, religious 
groups were recoded into the largest and 
minority groups to extract results from our 
regression analysis. In many settings, 
more nuanced regression findings are 
possible, and a comprehensive regression 
analysis could reveal more informative 
country-specific determinants of vaccine 
uptake. 
Further research should investigate the 
link between political polarisation, 
religious extremism, and populism and 
vaccination beliefs to better understand 
these complex ties. Having a common 
metric of confidence and a baseline for 
comparison is crucial to understanding 
these changing trends over time, which 
can serve as an early warning system to 
prompt needed intervention to avert drops 
in vaccine confidence and acceptance. 
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